TMEM66 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.409800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.059000E-01
Normal-vs-Stage2
4.455600E-01
Normal-vs-Stage3
1.611600E-01
Normal-vs-Stage4
9.211000E-01
Stage1-vs-Stage2
6.621000E-01
Stage1-vs-Stage3
2.095200E-01
Stage1-vs-Stage4
4.744400E-01
Stage2-vs-Stage3
5.089400E-01
Stage2-vs-Stage4
3.212600E-01
Stage3-vs-Stage4
1.716440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.565200E-01
Normal-vs-AfricanAmerican
9.427000E-01
Normal-vs-Asian
3.320800E-01
Caucasian-vs-AfricanAmerican
7.546400E-01
Caucasian-vs-Asian
3.705400E-01
AfricanAmerican-vs-Asian
1.935170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.014800E-01
Normal-vs-Female
6.607800E-01
Male-vs-Female
7.013400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.992400E-01
Normal-vs-Age(41-60Yrs)
8.850000E-01
Normal-vs-Age(61-80Yrs)
7.921600E-01
Normal-vs-Age(81-100Yrs)
1.617980E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.858000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.887000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.965600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.192820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.237100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.579560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.091200E-01
Normal-vs-Daily Drinker
4.670200E-01
Normal-vs-Weekly Drinker
1.664630E-01
Normal-vs-Occasional Drinker
8.030800E-01
Normal-vs-Social Drinker
8.109600E-01
Non Drinker-vs-Daily Drinker
4.586600E-01
Non Drinker-vs-Weekly Drinker
8.460000E-01
Non Drinker-vs-Occasional Drinker
5.824300E-02
Non Drinker-vs-Social Drinker
2.681800E-01
Daily Drinker-vs-Weekly Drinker
4.445600E-01
Daily Drinker-vs-Occasional Drinker
1.467430E-01
Daily Drinker-vs-Social Drinker
5.324400E-01
Weekly Drinker-vs-Occasional Drinker
5.401500E-02
Weekly Drinker-vs-Social Drinker
2.485000E-01
Occasional Drinker-vs-Social Drinker
4.149000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.278400E-01
Normal-vs-Grade 2
1.343950E-02
Normal-vs-Grade 3
1.812330E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.102180E-01
Grade 1-vs-Grade 3
9.010400E-02
Grade 1-vs-Grade 4
3.278400E-01
Grade 2-vs-Grade 3
5.990400E-01
Grade 2-vs-Grade 4
1.343950E-02
Grade 3-vs-Grade 4
1.812330E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.329000E-01
Normal-vs-NonDiabetic
8.943000E-01
Diabetic-vs-NonDiabetic
4.015600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.828360E-02
Normal-vs-NoPancreatitis
9.069400E-01
Pancreatitis-vs-NoPancreatitis
1.576760E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.664600E-01
Normal-vs-N1
4.915200E-01
N0-vs-N1
2.991400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.538400E-01
Normal-vs-TP53-NonMutant
5.777800E-01
TP53-Mutant-vs-TP53-NonMutant
4.290100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
